<DOC>
	<DOCNO>NCT01109914</DOCNO>
	<brief_summary>The aim study verify whether vaccination Dukoral® ( SBL Vaccines ) induce immune response renal transplant recipient prednisolone combination either calcineurin inhibitor CNI ) mycophenolate mofetil ( MMF ) .</brief_summary>
	<brief_title>Mucosal Response Immunocompromised Host</brief_title>
	<detailed_description>BACKGROUND : LT-ETEC common cause traveler ' diarrhoea . Dukoral® ( SBL Vaccines ) reduce severity duration LT-ETEC induce diarrhea . Dehydration due diarrhea pose risk health renal transplant recipient . Therefore Dukoral may benefit group traveler . AIM OF THIS STUDY : Primary objective : To verify whether vaccination Dukoral® ( SBL Vaccines ) induce immune response renal transplant recipient prednisolone combination either calcineurin inhibitor ( cyclosporine tacrolimus ) mycophenolate mofetil . Secondary objective : To evaluate extent , immune response differs , depend use different class immunosuppressive drug ( CNI MMF ) . STUDY DESIGN : Single center interventional study . Population : The population base study consist adult renal transplant recipient receive transplant medical center . The control population consist healthy partner sibling renal transplant recipient . We intend include 10 healthy volunteer 60 renal transplant recipient ( 20 prednisolone CNI 20 prednisolone MMF ) . Intervention : Dukoral® ( SBL Vaccines ) administer orally baseline ( day 0 ) day 14 . Laboratory analysis : Serum CTB antibody ( ELISA ) , Vibriocidal assay . The analysis perform Crucell . Statistical analysis : No formal sample-size calculation perform . The crude outcome estimate adjust variable may influence outcome ( age , time transplantation , past treatment transplant rejection , current renal function , cumulative prednisolone dose , serum concentration ( i.e . area curve ) CNI MMF . Note : study intend also recruit study arm consist patient mTORi . Recruitment study arm unsuccesful due scarcity elligible patient .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>HEALTHY VOLUNTEERS Inclusion criterion : Above 18 year age Informed consent History autoimmune disease ( SLE , ANCA associate vasculitis , Goodpasture , Henoch Schonlein , cryoglobulinemia , secondary vasculitis , polyarteritis nodosa immunodeficiency disorder like IgA deficiency ) Chronic infection Past vaccination Dukoral another cholera ETEC vaccine History infection Vibrio cholerae Episode diarrhoea 6 month prior inclusion Allergy vaccinespecific component History severe allergic reaction vaccine Treatment blood product 3 month prior inclusion Current pregnancy breastfeed Premenopausal woman willing use contraceptive first 60 day vaccination Use immunosuppressive drug RENAL TRANSPLANT RECIPIENTS Above 18 year age Creatinin clearance ≥ 40 ml/min measure 6 month prior inclusion Stable renal function 1 year prior inclusion Stable immunosuppressive regimen CNI , MMF mTORi combine prednisolone least 3 month prior inclusion Informed Consent History autoimmune disease ( SLE , ANCA associate vasculitis , Goodpasture , Henoch Schonlein , cryoglobulinemia , secondary vasculitis , polyarteritis nodosa immunodeficiency disorder like IgA deficiency ) Chronic infection Treatment rejection transplant past 1 year prior inclusion Past vaccination Dukoral another cholera ETEC vaccine History infection Vibrio cholerae Episode diarrhoea 6 month prior inclusion Allergy vaccinespecific component History severe allergic reaction vaccine Treatment blood product 3 month prior inclusion Current pregnancy breastfeed Premenopausal woman willing use contraceptive first 60 day vaccination Use immunosuppressive drug CNI , MMF , mTORi prednisolone time inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Renal transplantation</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>ETEC</keyword>
	<keyword>Dukoral</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Immunity , Humoral</keyword>
</DOC>